glp 1 and macular degeneration The potential risk of age-related with GLP-1 drugs in people with diabetes https://t.co/BoGo9iTutV The Impact of GLP-1 Receptor
Description
After 30 weeks, exenatide once weekly reduced A1C significantly more compared with the twice daily formulation (1.9% versus 1.5%
They can cost more than $1,000 a month, and they must be taken for the long term to prevent people from regaining weight
NAION involves reduced blood supply to the optic nerve, and it often presents as sudden, painless vision loss or a shadow/curtain effect in one eye, sometimes noticed upon waking
For degludec and liraglutide alone groups, the differences of the A1c reductions were not significant between baseline oral drugs subgroups
we recommend confirming with your FSA administrator
